Related Experiment Videos
Neural tube defects: epidemiology, detection, and prevention
Insights
Neural tube defects, like spina bifida, can be detected before birth. Maternal serum screening for alpha-fetoprotein offers a way to identify at-risk pregnancies for early intervention.
Area of Science:
- Obstetrics and Gynecology
- Developmental Biology
- Medical Diagnostics
Background:
- Neural tube defects (NTDs) are prevalent congenital central nervous system malformations, including anencephaly, spina bifida, and encephalocele.
- Prenatal diagnosis of NTDs is possible through amniotic fluid analysis of alpha-fetoprotein (AFP) in high-risk pregnancies.
- Maternal serum screening for elevated AFP levels is now a national standard, enabling identification of at-risk women previously unknown.
Purpose of the Study:
- To discuss the epidemiology, detection, screening, and prevention of neural tube defects.
- To explain the role and utility of alpha-fetoprotein (AFP) in prenatal screening for NTDs.
Main Methods:
- Review of epidemiological data on neural tube defects.
- Explanation of diagnostic methods for NTDs, focusing on amniotic fluid AFP analysis.
- Description of maternal serum screening protocols for elevated AFP levels.
Main Results:
- Maternal serum screening for AFP significantly expands the identification of pregnancies at risk for NTDs.
- Early detection through AFP screening facilitates timely medical intervention and management.
- Understanding NTD epidemiology informs targeted prevention strategies.
Conclusions:
- Maternal serum screening for alpha-fetoprotein is a valuable tool for identifying pregnancies at risk for neural tube defects.
- This screening method enhances prenatal detection, enabling earlier intervention and improved outcomes.
- Comprehensive strategies encompassing epidemiology, detection, screening, and prevention are crucial for managing NTDs.
Abstract:
Neural tube defects are common congenital malformations of the central nervous system and include anencephaly, spina bifida, and encephalocele. Prenatal detection by amniotic fluid analysis of alpha-fetoprotein is possible in those women known to be at high risk for neural tube defects. Maternal serum screening for increased alpha-fetoprotein levels is now available nationally and has the potential to identify women who otherwise would not be known to be at risk. The epidemiology, detection, screening, and prevention of neural tube defects are discussed, and an explanation of alpha-fetoprotein and its use in screening is offered.